The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zafrilla 2mg tablets

2 milligram(s) Tablet

Gedeon Richter PlcPA1330/023/001

Main Information

Trade NameZafrilla 2mg tablets
Active SubstancesDienogest
Strength2 milligram(s)
Dosage FormTablet
Licence HolderGedeon Richter Plc
Licence NumberPA1330/023/001

Group Information

ATC CodeG03DB08 dienogest

Status

Authorised/WithdrawnAuthorised
Licence Issued12/04/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back